1.GD3 Accumulation in Cell Surface Lipid Rafts Prior to Mitochondrial Targeting Contributes to Amyloid-beta-induced Apoptosis.
Jong Kook KIM ; Sang Ho KIM ; Hee Young CHO ; Hee Soo SHIN ; Hye Ryen SUNG ; Jin Ran JUNG ; Mei Lian QUAN ; Dong Hong JIANG ; Hae Rahn BAE
Journal of Korean Medical Science 2010;25(10):1492-1498
Neuronal apoptosis induced by amyloid beta-peptide (A beta) plays an important role in the pathophysiology of Alzheimer's disease (AD). However, the molecular mechanism underlying A beta-induced apoptosis remains undetermined. The disialoganglioside GD3 involves ceramide-, Fas- and TNF-alpha-mediated apoptosis in lymphoid cells and hepatocytes. Although the implication of GD3 has been suggested, the precise role of GD3 in A beta-induced apoptosis is still unclear. Here, we investsigated the changes of GD3 metabolism and characterized the distribution and trafficking of GD3 during A beta-induced apoptosis using human brain-derived TE671 cells. Extracellular A beta induced apoptosis in a mitochondrial-dependent manner. GD3 level was negligible in the basal condition. However, in response to extracellular A beta, both the expression of GD3 synthase mRNA and the intracellular GD3 level were dramatically increased. Neosynthesized GD3 rapidly accumulated in cell surface lipid microdomains, and was then translocated to mitochondria to execute the apoptosis. Disruption of membrane lipid microdomains with methyl-beta-cyclodextrin significantly prevented both GD3 accumulation in cell surface and A beta-induced apoptosis. Our data suggest that rapidly accumulated GD3 in plasma membrane lipid microdomains prior to mitochondrial translocation is one of the key events in A beta-induced apoptosis.
Amyloid beta-Peptides/*pharmacology
;
*Apoptosis
;
Cell Line
;
Gangliosides/*metabolism/physiology
;
Humans
;
Membrane Microdomains/*metabolism
;
Mitochondria/*metabolism
;
Sialyltransferases/genetics/metabolism
;
beta-Cyclodextrins/pharmacology
2.Protein kinase A mediates microglial activation induced by plasminogen and gangliosides.
Kyoung Jin MIN ; Myung Soon YANG ; Ilo JOU ; Eun hye JOE
Experimental & Molecular Medicine 2004;36(5):461-467
In the injured brain, microglia is known to be activated and produce proinflammatory mediators such as interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS). We investigated the role of protein kinase A (PKA) in microglial activation by both plasminogen and gangliosides in rat primary microglia and in the BV2 immortalized murine microglial cell line. Both plasminogen and gangliosides induced IL-1beta, TNF-alpha and iNOS mRNA expression, and that this expression was inhibited by the addition of the PKA inhibitors, KT5720 and H89. Both plasminogen and gangliosides activated PKA and increased the DNA binding activity of the cAMP response element- binding protein (CREB). Furthermore, KT5720 and H89 reduced the DNA binding activities of CREB and NF-kappaB in plasminogen-treated cells. These results suggest that PKA plays an important role in plasminogen and gangliosides- induced microglial activation.
Animals
;
Carbazoles/pharmacology
;
Cell Line
;
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors/*physiology
;
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism
;
DNA-Binding Proteins/metabolism
;
Gangliosides/pharmacology/*physiology
;
Gene Expression Regulation
;
Indoles/pharmacology
;
Interleukin-1/genetics
;
Isoquinolines/pharmacology
;
Mice
;
Microglia/drug effects/*enzymology/*immunology
;
NF-kappa B/metabolism
;
Nitric-Oxide Synthase/genetics
;
Plasminogen/pharmacology/*physiology
;
Pyrroles/pharmacology
;
RNA, Messenger/analysis/metabolism
;
Rats
;
Research Support, Non-U.S. Gov't
;
Sulfonamides/pharmacology
;
Tumor Necrosis Factor-alpha/genetics